Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2020

May 12, 2020

29755_dirs_2020-05-12_823b4a57-a2d9-442d-81ef-7e952a80f540.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-04-28

Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-28 Common Stock, $0.01 par value G 21800 Disposed 356092 Direct
2020-04-28 Common Stock, $0.01 par value G 10900 Acquired 17615 Indirect
2020-04-28 Common stock, $0.01 par value G 5450 Acquired 5900 Indirect
2020-04-28 Common Stock, $0.01 par value G 5450 Acquired 5900 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities.